retatrutide eli lilly phase 2 results just announced striking 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% An experimental weight-loss drug from

Patients with alcohol use disorder may have unique safety considerations when using GLP-1 medications

The Saxenda Spin-Off: Another Weight Management Star While Ozempic and Wegovy have garnered much attention, let's not forget another GLP-1 receptor agonist family member that's been turning heads in the weight management world for years now: Saxenda (liraglutide)

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

With a Net capacity of 6.22 cubic feet this efficient Undercounter Refrigerator is perfect for tight kitchens

Eventually, the FDA approved GLP-1 drugs specifically for it, Dr

These posture adjustments can help reduce straining and improve emptying